Healthcare+ Expo, Taiwan 2023： Memory T-Cell Immunotherapy Brings New Hope for Cancer Patients
To deepen the understanding of cancer treatment among visitors, Luka Biomedical hosted two high-quality cancer medical seminars. These seminars were led by Dr. and Professor Chen Guang-Yao, Consultant of the Particle Therapy and Radiation Oncology Department at Taipei Veterans General Hospital; Dr. Xie Ying-Hua, Chief Professor at Chang Gung Memorial Hospital; Dr. Liu Bing-Zhong, Convener and Executive Physician at Banqiao Zhongxing Hospital's Cell Therapy Center; and Dr. Tang Zhi-Chao, Chairman of Luka Biomedical and an expert in immune cell cancer therapy.
These doctors and experts explained that immune cell cancer therapy is a non-toxic, non-invasive green treatment with very low and mild side effects, allowing patients to maintain their quality of life during cancer treatment. Among all immune cell therapies, memory T-cell therapy possesses immunological memory and specificity, with a long survival cycle that can last over a year in the human body. In case of cancer recurrence, these cells can be reactivated to eliminate cancer cells, offering a significant advantage in preventing cancer recurrence. These two high-quality seminars not only provided deeper cancer knowledge but also addressed many questions from the audience, encouraging more people to bravely make decisions regarding cancer treatment.
